» Authors » Oreste Perrella

Oreste Perrella

Explore the profile of Oreste Perrella including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 24
Citations 119
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Quartuccio L, Zuliani F, Corazza L, Scaini P, Zani R, Lenzi M, et al.
J Autoimmun . 2015 Aug; 63:88-93. PMID: 26255249
Objective: To evaluate the efficacy and safety in the long term of a retreatment regimen with Rituximab (RTX) alone administered at clinical relapse in cryoglobulinemic vasculitis (CV). Methods: Thirty patients...
2.
Perrella A, DAntonio A, Sbreglia C, Sorrentino P, Conca P, Atripaldi L, et al.
Pathog Dis . 2014 Jun; 72(2):124-30. PMID: 24891135
We aimed to verify whether CD4(+)/CD25(+) T cells suppress CD4(+) T cells and secrete Granzyme B (GZB) during acute and chronic hepatitis C (CHC) infection. We enrolled 50 subjects: 20...
3.
Manangeeswaran M, Jacques J, Tami C, Konduru K, Amharref N, Perrella O, et al.
Gastroenterology . 2012 Mar; 142(7):1516-25.e3. PMID: 22430395
Background & Aims: CD4+ T-regulatory (Treg) cells suppress immune responses and control self-tolerance and immunity to pathogens, cancer, and alloantigens. Most pathogens activate Treg cells to minimize immune-mediated tissue damage...
4.
Sorrentino P, Castaldo G, Tarantino L, Bracigliano A, Perrella A, Perrella O, et al.
J Gastroenterol Hepatol . 2011 Dec; 27(4):813-22. PMID: 22142548
Background And Aim: Refractory ascites in liver-cirrhosis is associated with a poor prognosis. We performed a prospective study to investigate whether aggressive nutritional-support could improve outcomes in cirrhotic patients. Methods:...
5.
Sorrentino P, Terracciano L, DAngelo S, Ferbo U, Bracigliano A, Tarantino L, et al.
J Gastroenterol . 2010 Apr; 45(10):1053-62. PMID: 20393861
Background: Factors responsible for the progression of primary biliary cirrhosis (PBC) are still poorly understood. In the present study, we investigated the associations between the stage of PBC and the...
6.
Buonaguro L, Petrizzo A, Tornesello M, Napolitano M, Martorelli D, Castello G, et al.
J Transl Med . 2010 Feb; 8:18. PMID: 20170491
Hepatitis C virus (HCV) is one of the major risk factors for chronic hepatitis, which may progress to cirrhosis and hepatocellular carcinoma, as well as for type II mixed cryoglobulinemia...
7.
Morelli G, Perrella A, Sbreglia C, Bellopede P, Riccio V, Monaco A, et al.
Infect Agent Cancer . 2009 Apr; 4:5. PMID: 19338663
Correction to Morelli G, Perrella A, Sbreglia C, Bellopede P, Riccio V, Perrella O: Antiviral therapy in acute viral hepatitis B: why and when. Infectious Agents and Cancer 2009, 4:2.
8.
Perrella A, Grattacaso S, DAntonio A, Atripaldi L, Sbreglia C, Gnarini M, et al.
Am J Infect Control . 2009 Jan; 37(5):426-429. PMID: 19155099
Background: Few studies are available on possible hepatitis C virus (HCV)-specific T-cell immune response in health care workers (HCWs) involved in the care of patients with HCV infection. We aimed...
9.
Morelli G, Perrella A, Sbreglia C, Bellopede P, Riccio V, Perrella O
Infect Agent Cancer . 2009 Jan; 4:2. PMID: 19149879
Acute viral hepatitis B is cleared in more than 95% of patients, while the remainder ones may develop either chronic HBV infection or, rarely, fulminant hepatitis.Therefore there are elderly patients...
10.
Buonaguro L, Petrizzo A, Tagliamonte M, Vitone F, Re M, Pilotti E, et al.
Infect Agent Cancer . 2008 Oct; 3:13. PMID: 18847472
Objective: The continuous identification of HIV-1 non-B subtypes and recombinant forms in Italy indicates the need of constant molecular epidemiology survey of genetic forms circulating and transmitted in the resident...